UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
OCTOBER 3, 2013
Date of Report (Date of earliest event reported)
MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 0-11740
|
COLORADO |
|
84-0872291 |
|
(State or other jurisdiction of |
|
(I.R.S. Employer |
|
12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO |
|
80228 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (303) 987-8000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on October 3, 2013. Of the 3,402,710 shares of common stock entitled to vote, 2,797,279 were represented either in person or proxy. Seven directors were elected to serve until the next Annual Meeting of Shareholders. The advisory vote to approve executive compensation was approved. The shareholders voted, on an advisory basis, as set forth below on the frequency of future advisory votes on executive compensation. The ratification of the appointment of EKS&H LLLP as the Company’s independent auditors for the year ending March 31, 2014 was approved.
The seven directors elected were:
|
|
|
|
|
|
|
Broker |
|
|
|
|
For |
|
Withheld |
|
Non-Votes |
|
|
Luke R. Schmieder |
|
1,438,178 |
|
621,640 |
|
737,461 |
|
|
John J. Sullivan, Ph.D. |
|
2,038,934 |
|
20,884 |
|
737,461 |
|
|
Michael T. Brooks |
|
2,018,663 |
|
41,155 |
|
737,461 |
|
|
H. Stuart Campbell |
|
1,899,835 |
|
159,983 |
|
737,461 |
|
|
Robert V. Dwyer |
|
2,028,181 |
|
31,637 |
|
737,461 |
|
|
Evan C. Guillemin |
|
2,019,609 |
|
40,209 |
|
737,461 |
|
|
David M. Kelly |
|
2,021,559 |
|
38,259 |
|
737,461 |
|
The advisory vote to approve executive compensation was approved by the following vote:
|
|
|
|
|
|
|
Broker |
|
|
For |
|
Against |
|
Abstain |
|
Non-Votes |
|
|
1,931,285 |
|
51,362 |
|
77,171 |
|
737,461 |
|
The advisory vote on the frequency of future advisory votes on executive compensation was as follows:
|
Every |
|
Every |
|
Every |
|
|
|
Broker |
|
|
Year |
|
2 Years |
|
3 Years |
|
Abstain |
|
Non-Votes |
|
|
1,036,907 |
|
15,525 |
|
831,515 |
|
175,871 |
|
737,461 |
|
The appointment of EKS&H LLLP as the Company’s independent auditors for the year ending March 31, 2014 was approved by the following vote:
|
|
|
|
|
|
|
Broker |
|
|
For |
|
Against |
|
Abstain |
|
Non-Votes |
|
|
2,739,226 |
|
10,472 |
|
47,581 |
|
— |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
DATE: October 4, 2013 |
|
Mesa Laboratories, Inc. |
|
|
|
( Registrant) |
|
|
|
|
|
|
|
|
|
|
|
/s/ John J. Sullivan |
|
|
BY: |
John J. Sullivan, |
|
|
|
President and Chief Executive Officer |